Is BPC-157 banned? Peptides and anti-doping

A fighter tears something in week three of camp. Within a day somebody in the gym will mention a peptide that heals tendon, and it will be described as legal, natural and undetectable. All three claims are wrong, and the third one is the least important.

The clause that catches everything

Most fighters read the Prohibited List as a list of names. It is not, and category S0 is the reason. S0 covers any pharmacological substance with no current approval by any governmental regulatory health authority for human therapeutic use, and it is prohibited at all times. Drugs still in pre-clinical or clinical development sit there.

So do discontinued drugs, designer compounds, and substances approved only for veterinary use.

Read that again with a vial in your hand. The question is not whether the compound appears on a list. The question is whether any regulator anywhere has approved it as a medicine for people. If the answer is no, it is prohibited, and the fact that you could not find it on the List means nothing at all.

WADA names BPC-157 in that category directly, alongside 2,4-dinitrophenol and a set of compounds most athletes will never encounter. Everything in S0 is classified as a specified substance, which affects how a case is handled but not whether a violation occurred.

What BPC-157 actually is

A synthetic peptide of 15 amino acids, based on a partial sequence of a compound originally isolated from human gastric juice.

It has been studied mainly in animals, largely rodents, for soft tissue and tendon healing.

It was not prohibited before 2022. It was added to the 2022 Prohibited List under S0, and the reason is exactly the clause above: no regulator has approved it for human use, which also means there is no established safe dose, no established effective dose, and no route by which a physician can legitimately prescribe it to you.

TB-500 belongs in the same conversation, and so do the growth hormone releasing peptides sold under names like CJC-1295 and ipamorelin, and anything marketed as an IGF-1 product. Those sit somewhere different: section S2 of the List, peptide hormones, growth factors and related substances, prohibited at all times.

Sanctions involving both BPC-157 and TB-500 have already been issued in other sports.

One distinction is worth carrying. S0 substances, BPC-157 among them, are classified as specified substances. The S2 group is not. Being a specified substance does not make a violation smaller, but it changes what an athlete can argue about how the substance got there, and it changes how the case runs from the first day.

"Research use only" is the answer, not a loophole

Peptides are sold from websites, wellness clinics and compounding suppliers that are not subject to the quality control applied to licensed medicines. The wording on the box is what allows that trade to exist.

A product labelled for research, or marked not for human consumption, is being sold outside the medicines system on purpose.

Fighters read that phrasing as clever. It is a legal position taken by a seller to avoid the regulation that would otherwise apply to them, and it transfers every risk in the transaction onto the person injecting it.

Nobody can tell you what is in the vial

Set the rules aside for a paragraph and the product still fails on its own terms. With no licensed manufacturing behind it, you cannot verify purity, actual strength, or whether the contents match the label. Manufacturing contamination is possible and undetectable by the buyer.

Dosing information comes from forums.

Then the anti-doping problem returns from a different direction, and this is the one that ends careers rather than camps: for an elite athlete the greatest risk is often whatever else is in the product, more than the peptide you believe you are taking. A vial contaminated with an anabolic agent produces a positive test for an anabolic agent, and your explanation will be that you were injecting an unapproved substance you bought online.

That is the same structural problem as supplement contamination, with none of the mitigations available.

Detection, and why it is the wrong question

Anti-doping laboratories have characterised BPC-157 and its metabolites by mass spectrometry, and detection methods have been published.

So the assumption that an obscure compound is invisible is out of date, and it was always a poor bet.

More to the point, a positive test is not the only route to a violation. Use and possession are violations in their own right, provable from messages, records, invoices and testimony without any sample at all.

Athletes have been sanctioned on that basis.

Why combat sport gets offered this more than most

The offer arrives at a predictable moment. There is a date on a contract, an injury that will not heal on the timeline the camp demands, and a fighter who is being paid to be ready.

Everyone around him wants a solution that costs a week rather than eight.

Add the culture. Combat sport moves fast, works through informal networks, and trusts personal recommendation over documentation. A vial handed over by a training partner who swears by it carries more weight in that room than a rulebook nobody has opened. Strict liability does not care.

What is in your body is your responsibility, and it stays your responsibility when someone else handed it to you.

The question to ask before the cap comes off

One question settles it, and it is not whether the substance is on the List.

Is this a licensed medicine, prescribed to me by a physician who knows I am a tested athlete, for a condition written in my medical record? Anything else is a no.

Not a maybe, not a check-it-later, not a conversation to have after camp.

And if you have already used one, say so to your doctor and to whoever advises you on anti-doping, before a test rather than after.

Every option that exists for an athlete in that position gets worse once a sample has been collected.